

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.92177691 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.81150945 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.81150945 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.49879582 |
| 5 | cellular response to type I interferon (GO:0071357) | 4.72041118 |
| 6 | type I interferon signaling pathway (GO:0060337) | 4.72041118 |
| 7 | response to type I interferon (GO:0034340) | 4.70798178 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.55288814 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.55288814 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.48550777 |
| 11 | response to interferon-beta (GO:0035456) | 4.19695187 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 4.02090164 |
| 13 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.95049600 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 3.85510568 |
| 15 | cellular response to interferon-beta (GO:0035458) | 3.85412535 |
| 16 | response to interferon-alpha (GO:0035455) | 3.82080971 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.75977069 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 3.74085573 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 3.64316869 |
| 20 | cellular response to exogenous dsRNA (GO:0071360) | 3.61970763 |
| 21 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.58486381 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 3.57292914 |
| 23 | detection of other organism (GO:0098543) | 3.56084299 |
| 24 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.55997022 |
| 25 | T cell migration (GO:0072678) | 3.53127162 |
| 26 | detection of bacterium (GO:0016045) | 3.44970754 |
| 27 | B cell mediated immunity (GO:0019724) | 3.44169006 |
| 28 | defense response to protozoan (GO:0042832) | 3.42528108 |
| 29 | leukocyte aggregation (GO:0070486) | 3.41486415 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36503581 |
| 31 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.32983778 |
| 32 | negative regulation of viral genome replication (GO:0045071) | 3.30461447 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.27835608 |
| 34 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.27774357 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 3.27130922 |
| 36 | ribosomal small subunit assembly (GO:0000028) | 3.26532669 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.25808875 |
| 38 | negative thymic T cell selection (GO:0045060) | 3.25032098 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 3.24629605 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.21266095 |
| 41 | negative T cell selection (GO:0043383) | 3.20157968 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.19534986 |
| 43 | response to host immune response (GO:0052572) | 3.19534986 |
| 44 | myeloid cell activation involved in immune response (GO:0002275) | 3.18697959 |
| 45 | microglial cell activation (GO:0001774) | 3.18616798 |
| 46 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18035114 |
| 47 | response to protozoan (GO:0001562) | 3.17545916 |
| 48 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.16622723 |
| 49 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.13965935 |
| 50 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.13700354 |
| 51 | detection of external biotic stimulus (GO:0098581) | 3.13319928 |
| 52 | regulation of RIG-I signaling pathway (GO:0039535) | 3.12874370 |
| 53 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.12266328 |
| 54 | cellular response to zinc ion (GO:0071294) | 3.12128969 |
| 55 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.08450811 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.06841259 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04703543 |
| 58 | detection of molecule of bacterial origin (GO:0032490) | 3.02903158 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02343909 |
| 60 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.00697550 |
| 61 | cytidine deamination (GO:0009972) | 2.99938296 |
| 62 | cytidine metabolic process (GO:0046087) | 2.99938296 |
| 63 | cytidine catabolic process (GO:0006216) | 2.99938296 |
| 64 | regulation of response to interferon-gamma (GO:0060330) | 2.99081741 |
| 65 | regulation of mast cell degranulation (GO:0043304) | 2.99030147 |
| 66 | cellular extravasation (GO:0045123) | 2.98252995 |
| 67 | respiratory burst (GO:0045730) | 2.98062850 |
| 68 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.97177016 |
| 69 | mast cell activation (GO:0045576) | 2.96361023 |
| 70 | cellular response to interleukin-15 (GO:0071350) | 2.95346491 |
| 71 | myeloid dendritic cell activation (GO:0001773) | 2.91779371 |
| 72 | response to peptidoglycan (GO:0032494) | 2.91499213 |
| 73 | regulation of mast cell activation (GO:0033003) | 2.91335535 |
| 74 | positive regulation of B cell differentiation (GO:0045579) | 2.90304656 |
| 75 | regulation of tolerance induction (GO:0002643) | 2.89987025 |
| 76 | interferon-gamma production (GO:0032609) | 2.88160231 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 2.85313833 |
| 78 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.83800449 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83747401 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.82196876 |
| 81 | response to host (GO:0075136) | 2.82196876 |
| 82 | response to host defenses (GO:0052200) | 2.82196876 |
| 83 | cellular response to virus (GO:0098586) | 2.81763219 |
| 84 | leukocyte degranulation (GO:0043299) | 2.81279942 |
| 85 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.80894173 |
| 86 | regulation of B cell differentiation (GO:0045577) | 2.80484674 |
| 87 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80261497 |
| 88 | positive regulation of humoral immune response (GO:0002922) | 2.79424272 |
| 89 | positive regulation of interferon-beta production (GO:0032728) | 2.79045746 |
| 90 | DNA deamination (GO:0045006) | 2.78195271 |
| 91 | positive thymic T cell selection (GO:0045059) | 2.77725457 |
| 92 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.77514846 |
| 93 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.77514846 |
| 94 | T-helper 1 type immune response (GO:0042088) | 2.77077508 |
| 95 | detection of biotic stimulus (GO:0009595) | 2.76867359 |
| 96 | macrophage activation (GO:0042116) | 2.76318476 |
| 97 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.75951573 |
| 98 | natural killer cell mediated immunity (GO:0002228) | 2.75951573 |
| 99 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.75436531 |
| 100 | NIK/NF-kappaB signaling (GO:0038061) | 2.73867060 |
| 101 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.73665762 |
| 102 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.73122786 |
| 103 | regulation of natural killer cell differentiation (GO:0032823) | 2.72235817 |
| 104 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.71906912 |
| 105 | cellular response to interferon-gamma (GO:0071346) | 2.71521727 |
| 106 | myeloid dendritic cell differentiation (GO:0043011) | 2.69883892 |
| 107 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.69040835 |
| 108 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68927443 |
| 109 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68741483 |
| 110 | natural killer cell activation (GO:0030101) | 2.67583354 |
| 111 | regulation of antigen processing and presentation (GO:0002577) | 2.66507299 |
| 112 | regulation of chemokine biosynthetic process (GO:0045073) | 2.66434492 |
| 113 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.63281738 |
| 114 | positive regulation of B cell mediated immunity (GO:0002714) | 2.63281738 |
| 115 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.62274270 |
| 116 | positive regulation of defense response to virus by host (GO:0002230) | 2.61322188 |
| 117 | neutrophil activation (GO:0042119) | 2.59764501 |
| 118 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.58587529 |
| 119 | response to interferon-gamma (GO:0034341) | 2.57587743 |
| 120 | regulation of defense response to virus by host (GO:0050691) | 2.56990547 |
| 121 | sequestering of actin monomers (GO:0042989) | 2.55745034 |
| 122 | modulation by symbiont of host defense response (GO:0052031) | 2.55727113 |
| 123 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.55727113 |
| 124 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.55727113 |
| 125 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.55727113 |
| 126 | modulation by symbiont of host immune response (GO:0052553) | 2.55727113 |
| 127 | positive regulation by symbiont of host defense response (GO:0052509) | 2.55727113 |
| 128 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.55080329 |
| 129 | regulation of T cell tolerance induction (GO:0002664) | 2.54121696 |
| 130 | granulocyte activation (GO:0036230) | 2.53977576 |
| 131 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.53863632 |
| 132 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.53597267 |
| 133 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.51945237 |
| 134 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.51130174 |
| 135 | defense response to virus (GO:0051607) | 2.50546732 |
| 136 | positive regulation of interleukin-12 production (GO:0032735) | 2.49503515 |
| 137 | positive regulation of isotype switching (GO:0045830) | 2.47606453 |
| 138 | response to interleukin-15 (GO:0070672) | 2.47101064 |
| 139 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.46325621 |
| 140 | leukocyte cell-cell adhesion (GO:0007159) | 2.46096152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.79012892 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.69408281 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.67185404 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.66789169 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.99570800 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.82558853 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.28671515 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06045836 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.98995456 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.95697939 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.78942801 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54946872 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49654151 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46576814 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.35674824 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30863906 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28880426 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.28595989 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.22664118 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.14902929 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14126696 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13665493 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.11183363 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.11109370 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.09914040 |
| 26 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.02127853 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.97225449 |
| 28 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.96413934 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.90217057 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.87836330 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79446408 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78706272 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77512800 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76894464 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.69482948 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66047882 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60843179 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57772036 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55714489 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54230160 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51686975 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.50042383 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50020073 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48034991 |
| 45 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47350869 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.46932337 |
| 47 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45386925 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45318578 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42642282 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42338133 |
| 51 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40759758 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40452260 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40303789 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39005270 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.36423272 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35574410 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34920688 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34503677 |
| 59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34367664 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.33404682 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32890344 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30313098 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28765839 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25114599 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24341095 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.23960094 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19749538 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17818226 |
| 69 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17476266 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16911587 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13126011 |
| 72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11103346 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10616788 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09888434 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08318795 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07892674 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05400742 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05077141 |
| 79 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.04664828 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03821068 |
| 81 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.01916164 |
| 82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01576701 |
| 83 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.01215584 |
| 84 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00972911 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00759590 |
| 86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00561728 |
| 87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.98435850 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97118056 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96427928 |
| 90 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95370534 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94861291 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94680231 |
| 93 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93972339 |
| 94 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93554768 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92595317 |
| 96 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92134753 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91269439 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89260178 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87433689 |
| 100 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.87226881 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86852996 |
| 102 | P300_27268052_Chip-Seq_Bcells_Human | 0.85600773 |
| 103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85185863 |
| 104 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82457765 |
| 105 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.81443001 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81257370 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81085634 |
| 108 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.81058219 |
| 109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80920063 |
| 110 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.80526938 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.80086969 |
| 112 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79838821 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79151820 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78518809 |
| 115 | GATA3_26560356_Chip-Seq_TH1_Human | 0.77018774 |
| 116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.76504051 |
| 117 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.76239088 |
| 118 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76228896 |
| 119 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76014361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.57920419 |
| 2 | MP0009785_altered_susceptibility_to | 3.82985322 |
| 3 | MP0003724_increased_susceptibility_to | 3.50499574 |
| 4 | MP0005671_abnormal_response_to | 3.41960472 |
| 5 | MP0000685_abnormal_immune_system | 3.36131721 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.94129468 |
| 7 | MP0005025_abnormal_response_to | 2.91271418 |
| 8 | MP0003436_decreased_susceptibility_to | 2.85578681 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.82479570 |
| 10 | MP0001790_abnormal_immune_system | 2.79160129 |
| 11 | MP0005387_immune_system_phenotype | 2.79160129 |
| 12 | MP0001800_abnormal_humoral_immune | 2.73352464 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.56941526 |
| 14 | MP0006082_CNS_inflammation | 2.53943899 |
| 15 | MP0002723_abnormal_immune_serum | 2.53628669 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.50555296 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.46715035 |
| 18 | MP0002419_abnormal_innate_immunity | 2.42242645 |
| 19 | MP0002006_tumorigenesis | 2.35477490 |
| 20 | MP0001819_abnormal_immune_cell | 2.34766567 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.33219106 |
| 22 | MP0001853_heart_inflammation | 2.16272848 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.08265461 |
| 24 | MP0002398_abnormal_bone_marrow | 1.97704862 |
| 25 | MP0004947_skin_inflammation | 1.95083015 |
| 26 | MP0002405_respiratory_system_inflammati | 1.94212529 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.93818173 |
| 28 | MP0000716_abnormal_immune_system | 1.89750411 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.86087214 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.76415174 |
| 31 | MP0008469_abnormal_protein_level | 1.71789713 |
| 32 | MP0001873_stomach_inflammation | 1.65997388 |
| 33 | MP0009764_decreased_sensitivity_to | 1.65573672 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.60744787 |
| 35 | MP0002429_abnormal_blood_cell | 1.58565842 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.58334735 |
| 37 | MP0002722_abnormal_immune_system | 1.57695834 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.56252578 |
| 39 | MP0005360_urolithiasis | 1.51109416 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.50912629 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.50912629 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.49929866 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.49651736 |
| 44 | MP0003866_abnormal_defecation | 1.48934098 |
| 45 | MP0003186_abnormal_redox_activity | 1.44060569 |
| 46 | MP0004510_myositis | 1.42909359 |
| 47 | MP0003303_peritoneal_inflammation | 1.35650393 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.33380623 |
| 49 | MP0005310_abnormal_salivary_gland | 1.32878272 |
| 50 | MP0000858_altered_metastatic_potential | 1.26676365 |
| 51 | MP0010234_abnormal_vibrissa_follicle | 1.21964392 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.19713483 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.19311578 |
| 54 | MP0008875_abnormal_xenobiotic_pharmacok | 1.15372092 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.13958757 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.13262979 |
| 57 | MP0003448_altered_tumor_morphology | 1.09031196 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.08136571 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.07973859 |
| 60 | MP0002933_joint_inflammation | 1.07174146 |
| 61 | MP0009763_increased_sensitivity_to | 1.06457853 |
| 62 | MP0009840_abnormal_foam_cell | 1.04404840 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.04300032 |
| 64 | MP0000490_abnormal_crypts_of | 1.03961252 |
| 65 | MP0000343_altered_response_to | 1.03479111 |
| 66 | MP0002132_abnormal_respiratory_system | 1.00711220 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.00417062 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 1.00299895 |
| 69 | MP0005365_abnormal_bile_salt | 0.96827324 |
| 70 | MP0006054_spinal_hemorrhage | 0.95127711 |
| 71 | MP0003252_abnormal_bile_duct | 0.91447874 |
| 72 | MP0008260_abnormal_autophagy | 0.90162292 |
| 73 | MP0000609_abnormal_liver_physiology | 0.86804224 |
| 74 | MP0005451_abnormal_body_composition | 0.85982236 |
| 75 | MP0001666_abnormal_nutrient_absorption | 0.85682902 |
| 76 | MP0009643_abnormal_urine_homeostasis | 0.83695544 |
| 77 | MP0003075_altered_response_to | 0.83561194 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.82798921 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.82182633 |
| 80 | MP0005164_abnormal_response_to | 0.82177071 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80878981 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 0.80731652 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.80449292 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.79371311 |
| 85 | MP0005166_decreased_susceptibility_to | 0.78356188 |
| 86 | MP0004883_abnormal_blood_vessel | 0.77438222 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.77247066 |
| 88 | MP0009278_abnormal_bone_marrow | 0.76915217 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 0.76770814 |
| 90 | MP0001764_abnormal_homeostasis | 0.73909136 |
| 91 | MP0008004_abnormal_stomach_pH | 0.72560419 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 0.71117326 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.71047130 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.70739050 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.69595765 |
| 96 | MP0000249_abnormal_blood_vessel | 0.68537064 |
| 97 | MP0003828_pulmonary_edema | 0.68413433 |
| 98 | MP0004381_abnormal_hair_follicle | 0.67526668 |
| 99 | MP0005174_abnormal_tail_pigmentation | 0.65958489 |
| 100 | MP0000598_abnormal_liver_morphology | 0.65913859 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.65239678 |
| 102 | MP0001986_abnormal_taste_sensitivity | 0.64906605 |
| 103 | MP0002254_reproductive_system_inflammat | 0.64147374 |
| 104 | MP0010329_abnormal_lipoprotein_level | 0.63116963 |
| 105 | MP0005390_skeleton_phenotype | 0.62985854 |
| 106 | MP0004147_increased_porphyrin_level | 0.62362899 |
| 107 | MP0001663_abnormal_digestive_system | 0.62337310 |
| 108 | MP0003195_calcinosis | 0.61923121 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.61475596 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.59658893 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.59506295 |
| 112 | MP0001851_eye_inflammation | 0.58770344 |
| 113 | MP0003045_fibrosis | 0.58072282 |
| 114 | MP0005084_abnormal_gallbladder_morpholo | 0.57705121 |
| 115 | MP0005165_increased_susceptibility_to | 0.56869030 |
| 116 | MP0008873_increased_physiological_sensi | 0.56223436 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.53589015 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.53083899 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.52844019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.17475456 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.09063144 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.95404594 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.53554608 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.28012252 |
| 6 | Myositis (HP:0100614) | 4.17161194 |
| 7 | Increased IgM level (HP:0003496) | 4.11592655 |
| 8 | Chronic otitis media (HP:0000389) | 3.98101114 |
| 9 | Autoimmune hemolytic anemia (HP:0001890) | 3.76254904 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.74484832 |
| 11 | Recurrent bronchitis (HP:0002837) | 3.72975954 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.63204634 |
| 13 | Recurrent viral infections (HP:0004429) | 3.46385794 |
| 14 | Vasculitis (HP:0002633) | 3.45012954 |
| 15 | Stomatitis (HP:0010280) | 3.34279874 |
| 16 | Pustule (HP:0200039) | 3.33439361 |
| 17 | Orchitis (HP:0100796) | 3.33420105 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.33199671 |
| 19 | IgM deficiency (HP:0002850) | 3.30834541 |
| 20 | Recurrent skin infections (HP:0001581) | 3.30707331 |
| 21 | Abnormality of T cells (HP:0002843) | 3.30528729 |
| 22 | Thrombocytosis (HP:0001894) | 3.27933829 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.26677923 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.26505075 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.17285281 |
| 26 | Optic neuritis (HP:0100653) | 3.17285281 |
| 27 | Petechiae (HP:0000967) | 3.08521860 |
| 28 | T lymphocytopenia (HP:0005403) | 3.08108536 |
| 29 | Abnormality of macrophages (HP:0004311) | 3.07880347 |
| 30 | Severe combined immunodeficiency (HP:0004430) | 3.07068296 |
| 31 | IgG deficiency (HP:0004315) | 3.00773613 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 2.99153531 |
| 33 | Combined immunodeficiency (HP:0005387) | 2.97116180 |
| 34 | Hypergammaglobulinemia (HP:0010702) | 2.94001211 |
| 35 | Nasal polyposis (HP:0100582) | 2.92006989 |
| 36 | Meningitis (HP:0001287) | 2.89949757 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 2.86572522 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.85334233 |
| 39 | Lymphopenia (HP:0001888) | 2.83730698 |
| 40 | Chronic diarrhea (HP:0002028) | 2.80548374 |
| 41 | Chest pain (HP:0100749) | 2.80311743 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.72812862 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.72812862 |
| 44 | Gingivitis (HP:0000230) | 2.71146892 |
| 45 | Gingival bleeding (HP:0000225) | 2.68434798 |
| 46 | Agammaglobulinemia (HP:0004432) | 2.67033450 |
| 47 | Cellulitis (HP:0100658) | 2.57445991 |
| 48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.55632574 |
| 49 | Joint swelling (HP:0001386) | 2.53229573 |
| 50 | Periodontitis (HP:0000704) | 2.53005722 |
| 51 | IgA deficiency (HP:0002720) | 2.49510189 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.46112113 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.45747654 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.44422642 |
| 55 | Leukocytosis (HP:0001974) | 2.44212594 |
| 56 | Basal ganglia calcification (HP:0002135) | 2.43820093 |
| 57 | Epistaxis (HP:0000421) | 2.42352646 |
| 58 | Gangrene (HP:0100758) | 2.42000825 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.40241006 |
| 60 | Pulmonary embolism (HP:0002204) | 2.39100212 |
| 61 | Thyroiditis (HP:0100646) | 2.38551915 |
| 62 | Obstructive lung disease (HP:0006536) | 2.38290974 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.38290974 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.35326672 |
| 65 | Hemoptysis (HP:0002105) | 2.34179852 |
| 66 | Encephalitis (HP:0002383) | 2.32169771 |
| 67 | Gastrointestinal stroma tumor (HP:0100723) | 2.31577825 |
| 68 | Increased serum ferritin (HP:0003281) | 2.31462341 |
| 69 | Acute hepatic failure (HP:0006554) | 2.31291250 |
| 70 | Arterial thrombosis (HP:0004420) | 2.30387062 |
| 71 | B lymphocytopenia (HP:0010976) | 2.29994505 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.29994505 |
| 73 | Urticaria (HP:0001025) | 2.29755140 |
| 74 | Abnormality of eosinophils (HP:0001879) | 2.29291278 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.27925235 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.27897875 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.27085492 |
| 78 | Abnormality of iron homeostasis (HP:0011031) | 2.25458441 |
| 79 | Recurrent sinusitis (HP:0011108) | 2.25019509 |
| 80 | Systemic lupus erythematosus (HP:0002725) | 2.22338445 |
| 81 | Prolonged bleeding time (HP:0003010) | 2.22025761 |
| 82 | Granulocytopenia (HP:0001913) | 2.21823625 |
| 83 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.21500918 |
| 84 | Purpura (HP:0000979) | 2.19986864 |
| 85 | Eosinophilia (HP:0001880) | 2.18953139 |
| 86 | Gastrointestinal inflammation (HP:0004386) | 2.17906639 |
| 87 | Prostate neoplasm (HP:0100787) | 2.17586582 |
| 88 | Hypochromic anemia (HP:0001931) | 2.17143345 |
| 89 | Recurrent pneumonia (HP:0006532) | 2.16944712 |
| 90 | Hypoplasia of the thymus (HP:0000778) | 2.15062678 |
| 91 | Colitis (HP:0002583) | 2.14354724 |
| 92 | Neutropenia (HP:0001875) | 2.13484888 |
| 93 | Chronic sinusitis (HP:0011109) | 2.12989132 |
| 94 | Keratoconjunctivitis (HP:0001096) | 2.12842560 |
| 95 | Aplastic anemia (HP:0001915) | 2.11982918 |
| 96 | Amaurosis fugax (HP:0100576) | 2.10649228 |
| 97 | Anorexia (HP:0002039) | 2.09362001 |
| 98 | Episodic fever (HP:0001954) | 2.09281183 |
| 99 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08458574 |
| 100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08458574 |
| 101 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08458574 |
| 102 | Abnormality of the prostate (HP:0008775) | 2.07184187 |
| 103 | Bronchitis (HP:0012387) | 2.05644095 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03427263 |
| 105 | Increased IgE level (HP:0003212) | 2.03144521 |
| 106 | Hypochromic microcytic anemia (HP:0004840) | 2.01272405 |
| 107 | Sepsis (HP:0100806) | 2.01091992 |
| 108 | Osteomyelitis (HP:0002754) | 2.00613968 |
| 109 | Recurrent lower respiratory tract infections (HP:0002783) | 2.00106131 |
| 110 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.99827759 |
| 111 | Skin ulcer (HP:0200042) | 1.99304317 |
| 112 | Lymphoma (HP:0002665) | 1.99117407 |
| 113 | Joint hemorrhage (HP:0005261) | 1.99034125 |
| 114 | Polyneuropathy (HP:0001271) | 1.98541238 |
| 115 | Microcytic anemia (HP:0001935) | 1.95038412 |
| 116 | Hypertensive crisis (HP:0100735) | 1.94481197 |
| 117 | Glomerulopathy (HP:0100820) | 1.94411382 |
| 118 | Skin rash (HP:0000988) | 1.94151986 |
| 119 | Hepatosplenomegaly (HP:0001433) | 1.92172853 |
| 120 | Thrombophlebitis (HP:0004418) | 1.91726699 |
| 121 | Poor head control (HP:0002421) | 1.90437181 |
| 122 | Arthralgia (HP:0002829) | 1.89804373 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 1.87639094 |
| 124 | Abnormal number of erythroid precursors (HP:0012131) | 1.85940066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.88239746 |
| 2 | MAP3K14 | 3.75616834 |
| 3 | MAP4K1 | 3.70392273 |
| 4 | TXK | 3.27239509 |
| 5 | TBK1 | 3.09244541 |
| 6 | TYK2 | 3.08086371 |
| 7 | IKBKE | 3.02446569 |
| 8 | JAK3 | 2.74863488 |
| 9 | IRAK4 | 2.37257952 |
| 10 | ZAP70 | 2.36794939 |
| 11 | BLK | 2.32201493 |
| 12 | KIT | 2.30387036 |
| 13 | KDR | 2.08550071 |
| 14 | FGFR4 | 2.03419307 |
| 15 | TEC | 1.95384598 |
| 16 | JAK1 | 1.91122225 |
| 17 | BTK | 1.86836467 |
| 18 | IKBKB | 1.85909632 |
| 19 | NME2 | 1.76703110 |
| 20 | PIM2 | 1.74828578 |
| 21 | ERN1 | 1.71810840 |
| 22 | MST4 | 1.68066886 |
| 23 | SYK | 1.56251994 |
| 24 | MAP3K13 | 1.54961536 |
| 25 | IRAK3 | 1.53516106 |
| 26 | RIPK4 | 1.46366354 |
| 27 | ITK | 1.44037584 |
| 28 | MAP3K12 | 1.43311144 |
| 29 | PBK | 1.41615395 |
| 30 | FLT3 | 1.41156176 |
| 31 | SCYL2 | 1.39943930 |
| 32 | CDK19 | 1.30914425 |
| 33 | CSK | 1.28971625 |
| 34 | LCK | 1.28183942 |
| 35 | CHUK | 1.22609830 |
| 36 | RPS6KA4 | 1.20820313 |
| 37 | FGFR3 | 1.18685384 |
| 38 | CSF1R | 1.15942406 |
| 39 | NLK | 1.15681260 |
| 40 | LYN | 1.14284634 |
| 41 | GRK6 | 1.11804197 |
| 42 | FGR | 1.09279969 |
| 43 | TGFBR2 | 1.07969129 |
| 44 | GRK7 | 1.06546388 |
| 45 | STK10 | 1.05753951 |
| 46 | TGFBR1 | 1.03307904 |
| 47 | ACVR1B | 0.92798884 |
| 48 | HCK | 0.92127376 |
| 49 | VRK2 | 0.91614639 |
| 50 | PIM1 | 0.90845608 |
| 51 | NEK9 | 0.90542251 |
| 52 | TIE1 | 0.90073313 |
| 53 | EIF2AK1 | 0.87761163 |
| 54 | JAK2 | 0.84554625 |
| 55 | RIPK1 | 0.83904216 |
| 56 | MAP2K3 | 0.83826238 |
| 57 | MATK | 0.83340631 |
| 58 | LRRK2 | 0.75189911 |
| 59 | TAOK2 | 0.73551269 |
| 60 | PRKG2 | 0.71225031 |
| 61 | ADRBK2 | 0.70667035 |
| 62 | PRPF4B | 0.70460142 |
| 63 | TESK2 | 0.68878284 |
| 64 | EIF2AK2 | 0.66885792 |
| 65 | PRKCQ | 0.66819800 |
| 66 | STK4 | 0.64419004 |
| 67 | MAP3K11 | 0.63816302 |
| 68 | MAP3K5 | 0.63675269 |
| 69 | RPS6KB2 | 0.59165892 |
| 70 | MYLK | 0.58734517 |
| 71 | MAPK11 | 0.54384781 |
| 72 | EPHA3 | 0.53848850 |
| 73 | DAPK1 | 0.53168298 |
| 74 | OXSR1 | 0.51665262 |
| 75 | IRAK1 | 0.49289996 |
| 76 | PRKCD | 0.49229222 |
| 77 | CLK1 | 0.48695318 |
| 78 | ARAF | 0.47179007 |
| 79 | PDK1 | 0.47165010 |
| 80 | TLK1 | 0.45934108 |
| 81 | MAP3K3 | 0.44186602 |
| 82 | SIK3 | 0.43022071 |
| 83 | EPHB1 | 0.42483471 |
| 84 | MST1R | 0.41566501 |
| 85 | STK16 | 0.40940272 |
| 86 | DAPK2 | 0.40703886 |
| 87 | FES | 0.39428742 |
| 88 | PTK6 | 0.39032647 |
| 89 | TAOK1 | 0.38280177 |
| 90 | HIPK2 | 0.38135330 |
| 91 | BCKDK | 0.37989798 |
| 92 | FYN | 0.37579775 |
| 93 | MAP2K6 | 0.37475255 |
| 94 | MAP4K2 | 0.37417859 |
| 95 | ABL1 | 0.37379968 |
| 96 | CAMKK2 | 0.36679274 |
| 97 | ZAK | 0.35299486 |
| 98 | PTK2B | 0.34976581 |
| 99 | TESK1 | 0.34764451 |
| 100 | IRAK2 | 0.33965235 |
| 101 | TRPM7 | 0.32753262 |
| 102 | BMPR2 | 0.32563637 |
| 103 | PIK3CG | 0.32050660 |
| 104 | ILK | 0.31376964 |
| 105 | IGF1R | 0.31022468 |
| 106 | MAP3K6 | 0.30976103 |
| 107 | ABL2 | 0.30629357 |
| 108 | RPS6KA6 | 0.29818780 |
| 109 | BMPR1B | 0.29800702 |
| 110 | MARK3 | 0.29598213 |
| 111 | MAPKAPK2 | 0.29221564 |
| 112 | VRK1 | 0.29174754 |
| 113 | MAPK7 | 0.28603746 |
| 114 | RPS6KA5 | 0.28346480 |
| 115 | FRK | 0.26939318 |
| 116 | EPHB2 | 0.25913277 |
| 117 | ADRBK1 | 0.25322274 |
| 118 | NUAK1 | 0.25102218 |
| 119 | EIF2AK3 | 0.24593784 |
| 120 | TNK2 | 0.24514660 |
| 121 | MAP3K10 | 0.23892234 |
| 122 | MAPK4 | 0.22539354 |
| 123 | MAP3K1 | 0.19817155 |
| 124 | EGFR | 0.18879334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.24240543 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.22179646 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.11171425 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.79415303 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.78889189 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.59560528 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.57254130 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.47632865 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.46081468 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.38146850 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26775963 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.13890142 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.10544479 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09630103 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.96874694 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.87681749 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.77671353 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.75552820 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66112843 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.64801753 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.62847640 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.62802838 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60986029 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.60719857 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53162260 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.52765340 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46229228 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43722611 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42666807 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40218811 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.35495893 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34437411 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.28335892 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27827494 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23011461 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 1.22088138 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.14073886 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12791689 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.11444421 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.09275934 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.08967332 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03416556 |
| 43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.00108766 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 0.99952026 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 0.99691056 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.97446153 |
| 47 | Protein export_Homo sapiens_hsa03060 | 0.96135851 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.94645239 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94305084 |
| 50 | DNA replication_Homo sapiens_hsa03030 | 0.94026184 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.92274381 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91900828 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88012874 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85799907 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82638692 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81869566 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81020593 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80474077 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78016544 |
| 60 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.71790422 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66096153 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61801206 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.61795294 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61096206 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59261565 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57559864 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57032085 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.55335785 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55101591 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53893001 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53612617 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53238683 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50369996 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49233201 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48952018 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48877986 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48821909 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48760717 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48586210 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.47822894 |
| 81 | Mismatch repair_Homo sapiens_hsa03430 | 0.47122211 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46967864 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45499378 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45253932 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.43510429 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42530351 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.42253991 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42076149 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41575252 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41097674 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40125416 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39853966 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39600884 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38157287 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37526821 |
| 96 | Homologous recombination_Homo sapiens_hsa03440 | 0.37364044 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.36731163 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36586633 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36449141 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35052058 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34557586 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34394021 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32815609 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32260431 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31422587 |
| 106 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30186015 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.29830774 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28932925 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27973860 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27551096 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.26911870 |
| 112 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.21122903 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20314061 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.20028217 |
| 115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.18504319 |
| 116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.17533639 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16324585 |
| 118 | Parkinsons disease_Homo sapiens_hsa05012 | 0.15508974 |
| 119 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.14439608 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10180491 |
| 121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.07616341 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.07444654 |
| 123 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.06781679 |
| 124 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.05956231 |
| 125 | RNA polymerase_Homo sapiens_hsa03020 | 0.05140490 |

